GENERALIZED EPIDERMOLYSIS BULLOSA SIMPLEX

Clinical trials for GENERALIZED EPIDERMOLYSIS BULLOSA SIMPLEX explained in plain language.

Never miss a new study

Get alerted when new GENERALIZED EPIDERMOLYSIS BULLOSA SIMPLEX trials appear

Sign up with your email to follow new studies for GENERALIZED EPIDERMOLYSIS BULLOSA SIMPLEX, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New ointment could ease painful blisters for kids and adults with rare skin disease

Disease control Ongoing

This study tests an ointment called diacerein 1% for people with a rare genetic skin condition called generalized epidermolysis bullosa simplex (EBS), which causes fragile skin and painful blisters. About 80 participants aged 6 months and older will receive either the ointment or…

Matched conditions: GENERALIZED EPIDERMOLYSIS BULLOSA SIMPLEX

Phase: PHASE2, PHASE3 • Sponsor: TWi Biotechnology, Inc. • Aim: Disease control

Last updated May 18, 2026 12:00 UTC

GENERALIZED EPIDERMOLYSIS BULLOSA SIMPLEX

Get alerted when new GENERALIZED EPIDERMOLYSIS BULLOSA SIMPLEX trials appear

New ointment could ease painful blisters for kids and adults with rare skin disease